Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
EBD Group
EBD Group
Activities:
Media
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Scleroderma treatment by Certa Therapeutics granted US FDA fast track
FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
Naobios and Sumagen sign exclusive partnership to develop HIV vaccine
Naobios will manage process development and initiate launch of cGMP manufacturing for phase II clinical trials
Rapid increase in purchasing teams expected at CPHI North America
Macro-uncertainty and large CDMO acquisitions attributed to have driven a surge in R&D, purchasing and QC/QA attendees at event
Bio-Rad and Oncocyte partner to commercialise transplant monitoring with Droplet Digital PCR
The collaboration aims to provide researchers with tools to enable transformational monitoring of key biomarkers in solid tissue transplants
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Nordic Life Science Days 2013
<b>14 - 15 October 2013</b><br> <i>Meeting</i><br> Stockholm, Sweden
Pharmaceutical
ChinaBio Partnering Forum 2013
<b>29 - 30 May 2013</b><br> <i>Forum</i><br> Beijing, China
Pharmaceutical
BIO-Europe 2013
<b>4 - 6 November 2013</b><br> <i>Conference</i><br> Vienna, Austria
Finance
Bio€quity Europe 2012
<b>15 - 16 May 2012</b><br> <i>Conference</i><br> Frankfurt, Germany
Pharmaceutical
BIO-Europe Spring
<b>11 - 13 March 2013</b><br> <i>Conference</i><br> Barcelona, Spain
Finance
BIO-Europe 2010
<b>15 - 17 November 2010</b><br> Munich, Germany
Subscribe now